RAFFA WEALTH MANAGEMENT, LLC’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.5K Buy
365
+30
+9% +$1.29K ﹤0.01% 313
2026
Q1
$12.3K Sell
335
-32
-9% -$1.52K ﹤0.01% 346
2025
Q4
$18.7K Buy
367
+30
+9% +$1.53K ﹤0.01% 274
2025
Q3
$18.7K Buy
337
+40
+13% +$2.34K ﹤0.01% 269
2025
Q2
$20.5K Sell
297
-56
-16% -$3.81K ﹤0.01% 272
2025
Q1
$24.5K Sell
353
-55
-13% -$4.54K 0.01% 198
2024
Q4
$35.1K Buy
408
+56
+16% +$6.06K 0.01% 175
2024
Q3
$41.9K Hold
352
0.01% 156
2024
Q2
$50.2K Hold
352
0.01% 195
2024
Q1
$45.2K Sell
352
-13
-4% -$1.55K 0.01% 199
2023
Q4
$37.8K Sell
365
-85
-19% -$8.41K 0.01% 147
2023
Q3
$40.9K Hold
450
0.01% 143
2023
Q2
$36.4K Hold
450
0.01% 153
2023
Q1
$35.8K Hold
450
0.01% 171
2022
Q4
$30.5K Sell
450
-126
-22% -$7.39K 0.01% 172
2022
Q3
$28.7K Hold
576
0.01% 176
2022
Q2
$32.1K Hold
576
0.01% 170
2022
Q1
$32K Buy
576
+32
+6% +$1.64K 0.01% 175
2021
Q4
$30.5K Hold
544
0.01% 186
2021
Q3
$26.1K Buy
544
+120
+28% +$5.8K 0.01% 172
2021
Q2
$17.8K Sell
424
-94
-18% -$3.64K 0.01% 205
2021
Q1
$17.5K Buy
518
+38
+8% +$1.35K 0.01% 209
2020
Q4
$16.8K Buy
480
+48
+11% +$1.66K 0.01% 199
2020
Q3
$15K Buy
432
+54
+14% +$1.8K 0.01% 201
2020
Q2
$12.4K Buy
378
+48
+15% +$1.53K ﹤0.01% 208
2020
Q1
$9.93K Buy
+330
New +$9.83K ﹤0.01% 207
2017
Q1
Sell
-76
Closed -$1.36K 702
2016
Q4
$1.36K Buy
76
+26
+52% +$471 ﹤0.01% 353
2016
Q3
$1.04K Hold
50
﹤0.01% 399
2016
Q2
$1.34K Hold
50
﹤0.01% 331
2016
Q1
$1.35K Hold
50
﹤0.01% 323
2015
Q4
$1.45K Hold
50
﹤0.01% 310
2015
Q3
$1.36K Hold
50
﹤0.01% 325
2015
Q2
$1.37K Hold
50
﹤0.01% 324
2015
Q1
$1.33K Hold
50
﹤0.01% 322
2014
Q4
$1.06K Hold
50
﹤0.01% 348
2014
Q3
$1.19K Buy
+50
New +$1.15K ﹤0.01% 312
2014
Q1
Sell
-250
Closed -$1.06K 586
2013
Q4
$1.06K Buy
+250
New +$4.36K ﹤0.01% 348

Other funds holding NVO

RAFFA WEALTH MANAGEMENT, LLC's NVO Position: Q2 2026 in Review

RAFFA WEALTH MANAGEMENT, LLC increased its Novo Nordisk (NVO) stake by 9% in Q2 2026, buying an estimated $1.29K and bringing the position to 365 shares worth $17.5K. The position accounts for ﹤0.01% of the portfolio, ranked #313.

RAFFA WEALTH MANAGEMENT, LLC first reported a position in NVO in Q4 2013 and has held it in 37 quarters since. The position peaked at $50.2K in Q2 2024. 478 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • RAFFA WEALTH MANAGEMENT, LLC held 365 shares of Novo Nordisk worth $17.5K as of Q2 2026.
  • RAFFA WEALTH MANAGEMENT, LLC bought 30 Novo Nordisk shares in Q2 2026, an estimated $1.29K.
  • Novo Nordisk made up ﹤0.01% of RAFFA WEALTH MANAGEMENT, LLC's portfolio in Q2 2026, its #313 holding.
  • RAFFA WEALTH MANAGEMENT, LLC first reported a position in Novo Nordisk in Q4 2013 and has held it in 37 quarters since.
  • RAFFA WEALTH MANAGEMENT, LLC's Novo Nordisk position peaked at $50.2K in Q2 2024.
  • 478 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on RAFFA WEALTH MANAGEMENT, LLC's 13F filing for Q2 2026, filed 27 Jul 2026.